Global Insomnia Medication Market Insights, Forecast to 2025

Table of Contents

1 Study Coverage

• 1.1 Insomnia Medication Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Insomnia Medication Market Size Growth Rate by Product
  • 1.4.2 Nonbenzodiazepine Receptor Agonists
  • 1.4.3 Benzodiazepine Receptor Agonists
  • 1.4.4 The Selective Melatonin Receptor Agonist Ramelteon
  • 1.4.5 Sedating Antidepressants
• 1.5 Market by End User
  • 1.5.1 Global Insomnia Medication Market Size Growth Rate by End User
  • 1.5.2 Adults
  • 1.5.3 Kids
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Insomnia Medication Market Size
  • 2.1.1 Global Insomnia Medication Revenue 2014-2025
  • 2.1.2 Global Insomnia Medication Sales 2014-2025
• 2.2 Insomnia Medication Growth Rate by Regions
  • 2.2.1 Global Insomnia Medication Sales by Regions
  • 2.2.2 Global Insomnia Medication Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Insomnia Medication Sales by Manufacturers
  • 3.1.1 Insomnia Medication Sales by Manufacturers
  • 3.1.2 Insomnia Medication Sales Market Share by Manufacturers
  • 3.1.3 Global Insomnia Medication Market Concentration Ratio (CR5 and HHI)
• 3.2 Insomnia Medication Revenue by Manufacturers
  • 3.2.1 Insomnia Medication Revenue by Manufacturers (2014-2019)
  • 3.2.2 Insomnia Medication Revenue Share by Manufacturers (2014-2019)
• 3.3 Insomnia Medication Price by Manufacturers
• 3.4 Insomnia Medication Manufacturing Base Distribution, Product Types
  • 3.4.1 Insomnia Medication Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Insomnia Medication Product Type
  • 3.4.3 Date of International Manufacturers Enter into Insomnia Medication Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Insomnia Medication Sales by Product
• 4.2 Global Insomnia Medication Revenue by Product
• 4.3 Insomnia Medication Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Insomnia Medication Breakdown Data by End User

6 North America

• 6.1 North America Insomnia Medication by Countries
  • 6.1.1 North America Insomnia Medication Sales by Countries
  • 6.1.2 North America Insomnia Medication Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Insomnia Medication by Product
• 6.3 North America Insomnia Medication by End User

7 Europe

• 7.1 Europe Insomnia Medication by Countries
  • 7.1.1 Europe Insomnia Medication Sales by Countries
  • 7.1.2 Europe Insomnia Medication Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Insomnia Medication by Product
• 7.3 Europe Insomnia Medication by End User

8 Asia Pacific

• 8.1 Asia Pacific Insomnia Medication by Countries
  • 8.1.1 Asia Pacific Insomnia Medication Sales by Countries
  • 8.1.2 Asia Pacific Insomnia Medication Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Insomnia Medication by Product
• 8.3 Asia Pacific Insomnia Medication by End User

9 Central & South America

• 9.1 Central & South America Insomnia Medication by Countries
  • 9.1.1 Central & South America Insomnia Medication Sales by Countries
  • 9.1.2 Central & South America Insomnia Medication Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Insomnia Medication by Product
• 9.3 Central & South America Insomnia Medication by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Insomnia Medication by Countries
  • 10.1.1 Middle East and Africa Insomnia Medication Sales by Countries
  • 10.1.2 Middle East and Africa Insomnia Medication Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Insomnia Medication by Product
• 10.3 Middle East and Africa Insomnia Medication by End User

11 Company Profiles

• 11.1 Eisai
  • 11.1.1 Eisai Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Eisai Insomnia Medication Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Eisai Insomnia Medication Products Offered
  • 11.1.5 Eisai Recent Development
• 11.2 Merck
  • 11.2.1 Merck Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Merck Insomnia Medication Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Merck Insomnia Medication Products Offered
  • 11.2.5 Merck Recent Development
• 11.3 Pfizer
  • 11.3.1 Pfizer Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Pfizer Insomnia Medication Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Pfizer Insomnia Medication Products Offered
  • 11.3.5 Pfizer Recent Development
• 11.4 Sanofi
  • 11.4.1 Sanofi Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Sanofi Insomnia Medication Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Sanofi Insomnia Medication Products Offered
  • 11.4.5 Sanofi Recent Development
• 11.5 Takeda
  • 11.5.1 Takeda Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 Takeda Insomnia Medication Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 Takeda Insomnia Medication Products Offered
  • 11.5.5 Takeda Recent Development
• 11.6 Vanda Pharmaceuticals
  • 11.6.1 Vanda Pharmaceuticals Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Vanda Pharmaceuticals Insomnia Medication Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Vanda Pharmaceuticals Insomnia Medication Products Offered
  • 11.6.5 Vanda Pharmaceuticals Recent Development
• 11.7 Astellas
  • 11.7.1 Astellas Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Astellas Insomnia Medication Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Astellas Insomnia Medication Products Offered
  • 11.7.5 Astellas Recent Development
• 11.8 Dainippon Sumitomo
  • 11.8.1 Dainippon Sumitomo Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 Dainippon Sumitomo Insomnia Medication Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 Dainippon Sumitomo Insomnia Medication Products Offered
  • 11.8.5 Dainippon Sumitomo Recent Development
• 11.9 ECR Pharmaceuticals (Valeant)
  • 11.9.1 ECR Pharmaceuticals (Valeant) Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 ECR Pharmaceuticals (Valeant) Insomnia Medication Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 ECR Pharmaceuticals (Valeant) Insomnia Medication Products Offered
  • 11.9.5 ECR Pharmaceuticals (Valeant) Recent Development
• 11.10 Flynn Pharma
  • 11.10.1 Flynn Pharma Company Details
  • 11.10.2 Company Business Overview
  • 11.10.3 Flynn Pharma Insomnia Medication Sales, Revenue and Gross Margin (2014-2019)
  • 11.10.4 Flynn Pharma Insomnia Medication Products Offered
  • 11.10.5 Flynn Pharma Recent Development
• 11.11 Johnson & Johnson
• 11.12 Meda
• 11.13 Somnus Therapeutics
• 11.14 Purdue Pharma
• 11.15 Neurim
• 11.16 Minerva Neurosciences
• 11.17 Pernix Therapeutics
• 11.18 SkyePharma
• 11.19 Paratek Pharmaceuticals

12 Future Forecast

• 12.1 Insomnia Medication Market Forecast by Regions
  • 12.1.1 Global Insomnia Medication Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Insomnia Medication Revenue Forecast by Regions 2019-2025
• 12.2 Insomnia Medication Market Forecast by Product
  • 12.2.1 Global Insomnia Medication Sales Forecast by Product 2019-2025
  • 12.2.2 Global Insomnia Medication Revenue Forecast by Product 2019-2025
• 12.3 Insomnia Medication Market Forecast by End User
• 12.4 North America Insomnia Medication Forecast
• 12.5 Europe Insomnia Medication Forecast
• 12.6 Asia Pacific Insomnia Medication Forecast
• 12.7 Central & South America Insomnia Medication Forecast
• 12.8 Middle East and Africa Insomnia Medication Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Insomnia Medication Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details